NCT02956525View on ClinicalTrials.gov

Phase I Study to Evaluate the Safety of Dexibuprofen 200mg Under Fasting and Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

July 1, 2018

Study Completion Date

July 1, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Dexibuprofen

Dexibuprofen 200 mg

Trial Locations (1)

13271-130

Azidus laboratories Ltd., Valinhos

Sponsors
All Listed Sponsors
lead

Apsen Farmaceutica S.A.

INDUSTRY

NCT02956525 - Phase I Study to Evaluate the Safety of Dexibuprofen 200mg Under Fasting and Fed Conditions | Biotech Hunter | Biotech Hunter